You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Atypical lobular hyperplasia

Showing 1 - 25 of 1,776
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Molecular Analysis of the Sloane Project

Enrolling by invitation
  • DCIS
  • +3 more
    • London, United Kingdom
      King's College London
    May 11, 2023

    Standard Breast Cancer Risk Assessment for African American and

    Not yet recruiting
    • Breast Atypical Ductal Hyperplasia
    • +3 more
    • Biospecimen Collection
    • +2 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Feb 22, 2023

    Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston

    Completed
    Has Results
    • Breast Atypical Ductal Hyperplasia
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2022

    Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each

    Recruiting
    • Atypical Hyperplasia
    • Lobular Carcinoma in Situ
    • Evanston, Illinois
    • +1 more
    Jan 20, 2023

    Impact of Dietary Inflammatory Potential on Breast Cancer Risk

    Not yet recruiting
    • Breast Atypical Ductal Hyperplasia
    • +4 more
    • Follow-Up
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 16, 2021

    Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,

    Not yet recruiting
    • Breast Atypical Hyperplasia
    • +3 more
    • Acolbifene Hydrochloride
    • +4 more
    • Duarte, California
    • +3 more
    Jul 11, 2023

    Atypical Hyperplasia of the Breast, Lobular Breast Carcinoma In Situ, Pleomorphic Lobular Breast Carcinoma In Situ Trial in

    Recruiting
    • Atypical Hyperplasia of the Breast
    • +2 more
    • Cancer Educational Materials
    • +3 more
    • Costa Mesa, California
    • +48 more
    Jan 9, 2023

    Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet

    Recruiting
    • Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
    • statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
    • Beijing, Beijing, China
      Peking University People's Hospital
    Oct 22, 2023

    Endometrial Cancer, Atypical Hyperplasia Trial (Ozempic, Mirena)

    Not yet recruiting
    • Endometrial Cancer
    • Atypical Hyperplasia
    • (no location specified)
    Oct 3, 2023

    Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)

    Recruiting
    • Atypical Endometrial Hyperplasia
    • Endometrial Carcinoma Stage I
    • Medroxyprogesterone acetate + Atorvastatin
    • Peking, Beijing, China
      Wang Jianliu
    Dec 29, 2022

    Atypical Ductal Hyperplasia, Ductal Carcinoma in Situ Trial in Milan (Vacuum-assisted excisional biopsy)

    Recruiting
    • Atypical Ductal Hyperplasia
    • Ductal Carcinoma in Situ
    • Vacuum-assisted excisional biopsy
    • Milan, Italy
      Breast Imaging Division, Radiology Department, IEO European Inst
    Jun 27, 2023

    Complex Atypical Hyperplasia, Endometrial Cancer Trial in Chapel Hill, Cincinnati (Metformin)

    Recruiting
    • Complex Atypical Hyperplasia
    • Endometrial Cancer
    • Chapel Hill, North Carolina
    • +1 more
    Jan 18, 2023

    Endometrial Tumors, Atypical Endometrial Hyperplasia, Progesterone Resistance Trial in Shanghai (GnRHa, Letrozole 2.5mg,

    Recruiting
    • Endometrial Neoplasms
    • +2 more
    • Shanghai, Shanghai, China
      Obstetrics and Gynecology Hospital, Fudan University
    Jul 29, 2022

    Endometrial Hyperplasia, Fertility Issues, Disease Regression Trial in Singapore (Mirena, Megace)

    Recruiting
    • Endometrial Hyperplasia
    • +3 more
    • Singapore, Singapore
    • +2 more
    Aug 5, 2022

    Endometrial Hyperplasia Trial in Winston-Salem (Megestrol Acetate, Levonorgestrel Drug Implant)

    Recruiting
    • Endometrial Hyperplasia
    • Megestrol Acetate
    • Levonorgestrel Drug Implant
    • Winston-Salem, North Carolina
      Wake Forest Baptist Health Sciences
    Aug 5, 2022

    Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity Trial in Shanghai (Intensive Lifestyle Intervention

    Recruiting
    • Atypical Endometrial Hyperplasia
    • +2 more
    • Intensive Lifestyle Intervention (ILI)
    • +2 more
    • Shanghai, China
      Obstetrics and Gynecology Hospital of Fudan University
    Jun 17, 2022

    Atypical Endometrial Hyperplasia Trial in Shanghai (Metformin plus Megestrol acetate, Megestrol Acetate)

    Terminated
    • Atypical Endometrial Hyperplasia
    • Metformin plus Megestrol acetate
    • Megestrol Acetate
    • Shanghai, Shanghai, China
      Obstetrics and Gynecology Hospital, Fudan University
    Mar 24, 2022

    Atypical Endometrial Hyperplasia, Obesity, Fertility Issues Trial in Shanghai (levonorgestrel-releasing intrauterine system,

    Recruiting
    • Atypical Endometrial Hyperplasia
    • +2 more
    • levonorgestrel-releasing intrauterine system
    • Polyethylene Glycol Loxenatide
    • Shanghai, Shanghai, China
      Obstetrics & Gynecology Hospital of Fudan University
    Jan 14, 2022

    Complex Atypical Hyperplasia, Endometrial Cancer Trial in Chapel Hill (18F-fluorofuranylnorprogesterone PET / MRI)

    Not yet recruiting
    • Complex Atypical Hyperplasia
    • Endometrial Cancer
    • 18F-fluorofuranylnorprogesterone PET / MRI
    • Chapel Hill, North Carolina
      University of North Carolina at Chapel Hill
    Jul 28, 2022

    Fertility Sparing Trial in Beijing (Medroxyprogesterone Acetate 500 MG Oral Tablet, Levonorgestrel-Releasing Intrauterine

    Recruiting
    • Fertility Sparing
    • Medroxyprogesterone Acetate 500 MG Oral Tablet
    • Levonorgestrel-Releasing Intrauterine System
    • Beijing, Beijing, China
      Bei Jing Chao-Yang Hospital
    Oct 3, 2022

    Atypical Endometrial Hyperplasia Trial in Shanghai (Megestrol Acetate, Rosuvastatin)

    Recruiting
    • Atypical Endometrial Hyperplasia
    • Shanghai, China
      Obstetrics and Gynecology Hospital, Fudan University
    Aug 17, 2021

    Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid

    Recruiting
    • Atypical Endometrial Hyperplasia
    • +2 more
    • Greeley, Colorado
    • +17 more
    Jun 13, 2022

    Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia Trial (No intervention)

    Not yet recruiting
    • Endometrial Carcinoma Stage I
    • Atypical Endometrial Hyperplasia
    • No intervention
    • (no location specified)
    Dec 3, 2022

    Endometrial Hyperplasia, Endometrial Cancer, Gynecologic Cancer Trial in Vancouver (Hysteroscopic uterine resection)

    Recruiting
    • Endometrial Hyperplasia
    • +2 more
    • Hysteroscopic uterine resection
    • Vancouver, British Columbia, Canada
      Vancouver General Hospital
    Oct 14, 2021

    Endometrial Atypical Hyperplasia, Endometrial Adenocarcinoma Trial in Shanghai, Hangzhou (Megestrol acetate and metformin,

    Completed
    Has Results
    • Endometrial Atypical Hyperplasia
    • Endometrial Adenocarcinoma
    • Megestrol acetate and metformin
    • Megestrol acetate
    • Shanghai, Shanghai, China
    • +4 more
    Sep 10, 2021